EUVIMEDEUVIMED entdecken
Crossref

KS483 MURINE MESENCHYMAL PROGENITOR CELLS AS DUAL IN VITRO MODEL FOR CHONDROGENIC AND OSTEOGENIC DIFFERENTIATION IN DRUG SCREENING

Katja Fagerlund, Natalia Kirillov, Jenni H. Mäki-Jouppila, Jukka P. Rissanen

Osteoarthritis and Cartilage · 2026-04 · 34 · S378

DOI: 10.1016/j.joca.2026.01.549 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Osteoarthritis and Cartilage, 2026-04. Verfasst von Katja Fagerlund und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Fagerlund, K., Kirillov, N., Mäki-Jouppila, J. H., & Rissanen, J. P. (2026). KS483 MURINE MESENCHYMAL PROGENITOR CELLS AS DUAL IN VITRO MODEL FOR CHONDROGENIC AND OSTEOGENIC DIFFERENTIATION IN DRUG SCREENING. Osteoarthritis and Cartilage, 34, S378. https://doi.org/10.1016/j.joca.2026.01.549

Vancouver

Fagerlund K, Kirillov N, Mäki-Jouppila JH, Rissanen JP. KS483 MURINE MESENCHYMAL PROGENITOR CELLS AS DUAL IN VITRO MODEL FOR CHONDROGENIC AND OSTEOGENIC DIFFERENTIATION IN DRUG SCREENING. Osteoarthritis and Cartilage. 2026;34:S378. doi:10.1016/j.joca.2026.01.549

BibTeX
@article{Fagerlund2026,
  author = {Fagerlund, Katja and Kirillov, Natalia and Mäki-Jouppila, Jenni H. and Rissanen, Jukka P.},
  title = {KS483 MURINE MESENCHYMAL PROGENITOR CELLS AS DUAL IN VITRO MODEL FOR CHONDROGENIC AND OSTEOGENIC DIFFERENTIATION IN DRUG SCREENING},
  journal = {Osteoarthritis and Cartilage},
  year = {2026},
  volume = {34},
  pages = {S378},
  doi = {10.1016/j.joca.2026.01.549}
}
Kostenlos starten →